The Sickle Cell Blood Drive with the American Red Cross runs 9 a.m. to 2 p.m. Saturday at Apostolic Church of Jesus Christ, 2420 SE Bellview Ave.

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

News 8 is once again honoring Black history by looking at health care and the racial disparities many report facing.

Sickle cell disease can take a toll on couples, but it's entirely possible to maintain a healthy relationship, says columnist.

In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine study has concluded that there could be a significant impact on cognitive ...

Q4 2024 Management View CEO Brian Goff highlighted the company's strategic focus on expanding the Pyrukynd franchise, with significant growth expected from the potential approval and launch in ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

The Rice lab of bioengineer Gang Bao and collaborators at Baylor College of Medicine have developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the ...

Researchers at Johns Hopkins Medicine have discovered that a drug originally developed for Alzheimer’s disease, schizophrenia ...